Update on $VPRB Brands – Expecting a Very Solid December

New Post Public Reply Private Reply Replies (0) Message Board
PROFIT$
219
Update on $VPRB Brands – Expecting a Very Solid December Quarter Report ( $900K - $1M Revenues )


http://globalsmallcaps.com/2017/03/13/2491/



This report provides an update to our October 2016 introduction to VPR Brands, LP and its recent entrance into the wholesale e-cigarette and vaping businesses.We think investors will be pleased with the upcoming December quarter results. We expect a minimum of $900,00 of revenue to be reported, but will not be surprised to see revenues in the $1.0 million range. We expect to see healthy sales and marketing spending within the income statement, which is something investors should support as the prospects for VPR to exert dominance within this rapidly changing sector are significant.We believe it is important to point our that vaping-related companies are now squarely addressing the growing cannabis opportunity as more states legalize.The Company in its current form is a result of the purchase of the wholesale assets of Vapor Corp. We believe these assets were the most solid of the Vapor Corp. portfolio. The brands being acquired are highly valued within the retail channel and among consumers.While the growth rate in the markets for e-cigarettes and vaping have slowed over the past year, strong long-term growth is predicted. It is also expected that cannabis legalization will have a positive effect on this sector.There are few people more qualified to lead this Company than CEO, Kevin Frija. He has been an industry insider for many years and is well prepared to navigate the fast changing regulatory environment occurring within this sector.We like this story and believe there are good odds this Company will be highly effective in navigating the very fast changing vaping marketplace.



It's only $, play at ur own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hyzon Motors Plans Delisting from Nasdaq—What This Means

Updated Category News Views 195

Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...

Continue Reading
Unlock the Potential of Crypto Staking with Keynode.net

Updated Category News Views 113

Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...

Continue Reading
Critical Updates for Rocket Pharmaceuticals Investors Amid Lawsuit

Updated Category News Views 263

Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...

Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference

Updated Category News Views 141

Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...

Continue Reading
SciBase's Strong Growth in Q1 2025: Key Highlights and Future

Updated Category News Views 222

Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...

Continue Reading